Paris, March 10, 2020 – The global law firm Bryan Cave Leighton Paisner (BCLP) has advised two U.S. health care investment funds, OrbiMed Advisors and Deerfield Management Company, on an $85 million financing agreement with the Valneva SE group, a specialist in infectious diseases. The agreement includes a $60 million fixed-rate loan (at a rate in the high single digits) and the ability to draw up to an additional $25 million on the same terms over the next 12 months. Repayment of the loan will commence in three years and the loan will mature in six years. The funds will be used to repay a loan previously granted by the European Investment Bank (EIB) and for rapid development of the Valneva Group’s two main clinical programs against Lyme disease and chikungunya. 

Legal participants in the transaction:

OrbiMed Advisors and Deerfield Management Company’s advisors:

  • Bryan Cave Leighton Paisner (BCLP) Paris:
    • Christian Sauer, Partner, Corporate
    • Olivier Borenstejn, Partner, Finance
    • Emmanuel Le Galloc'h, Associate, Finance
  • Covington & Burling 

Valneva’s advisors:

  • Dechert
  • Hogan Lovells Paris
    • Jean-Marc Franceschi, Partner, Corporate
    • Michel Quéré, Partner, Finance
    • Sophie Lok, Counsel, Finance
    • Ouassila El Asri, Associate, Finance

This document provides a general summary and is for information/educational purposes only. It is not intended to be comprehensive, nor does it constitute legal advice. Specific legal advice should always be sought before taking or refraining from taking any action.